Glenview Capital Management
$5.0B 13F equity value
53 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Glenview Capital Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| GPN | GLOBAL PMTS INC | 8,906,709 | $646M | 12.9% |
| CVS | CVS HEALTH CORP | 4,824,799 | $499M | 10.0% |
| THC | TENET HEALTHCARE CORP | 2,235,666 | $418M | 8.4% |
| TMO | THERMO FISHER SCIENTIFIC INC | 627,240 | $314M | 6.3% |
| AMZN | AMAZON COM INC | 1,271,687 | $303M | 6.1% |
| A | AGILENT TECHNOLOGIES INC | 1,969,541 | $262M | 5.2% |
| DHR | DANAHER CORP DEL | 1,145,979 | $218M | 4.4% |
| META | META PLATFORMS INC | 356,841 | $201M | 4.0% |
| AMD | ADVANCED MICRO DEVICES INC | 298,410 | $173M | 3.5% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 5,081,091 | $172M | 3.4% |
Track Glenview Capital Management's 13F portfolio: $5.0B in reported holdings, 53 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}